{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:25:26Z","timestamp":1790360726145,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1063010"],"award-info":[{"award-number":["DMS-1063010"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008284","name":"University of New Hampshire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008284","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009226","name":"National Security Agency","doi-asserted-by":"publisher","award":["H9823-10-1-0252"],"award-info":[{"award-number":["H9823-10-1-0252"]}],"id":[{"id":"10.13039\/100009226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005992","name":"Ministry of Education and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.toxlet.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T17:46:28Z","timestamp":1453139188000},"page":"106-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane"],"prefix":"10.1016","volume":"245","author":[{"given":"Megan E.","family":"Sawyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lider S.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris R.","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Croom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex A.","family":"Pegram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.toxlet.2016.01.008_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15287390802529872","article-title":"The usual suspects influence of physicochemical properties on lag time skin deposition and percutaneous penetration of nine model compounds","volume":"72","author":"Bo Nielsen","year":"2009","journal-title":"J. Toxicol. Environ. Health Part A"},{"issue":"3","key":"10.1016\/j.toxlet.2016.01.008_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10629369608032985","article-title":"Multilayered dermal subcompartments for modeling chemical absorption","volume":"5","author":"Bookout","year":"1996","journal-title":"SAR QSAR Environ. Res."},{"issue":"5","key":"10.1016\/j.toxlet.2016.01.008_bib0015","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s11095-014-1575-0","article-title":"In silico prediction of percutaneous absorption and disposition kinetics of chemicals","volume":"32","author":"Chen","year":"2015","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.toxlet.2016.01.008_bib0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1018981515480","article-title":"A new method for estimating dermal absorption from chemical exposure. 1. general approach","volume":"10","author":"Cleek","year":"1993","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.toxlet.2016.01.008_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.taap.2014.11.006","article-title":"Improving in vitro to in vivo extrapolation by incorporating toxicokinetic measurements: a case study of lindane-induced neurotoxicity","volume":"283","author":"Croom","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.toxlet.2016.01.008_bib0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/096032719701601103","article-title":"The percutaneous absorption and skin distribution of lindane in man I. in vivo studies","volume":"16","author":"Dick","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"issue":"11","key":"10.1016\/j.toxlet.2016.01.008_bib0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/096032719701601104","article-title":"The percutaneous absorption and skin distribution of lindane in man II. In vitro studies","volume":"16","author":"Dick","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"issue":"2","key":"10.1016\/j.toxlet.2016.01.008_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0892-0362(94)00064-K","article-title":"Repeated exposure to lindane leads to behavioral sensitization and facilitates electrical kindling","volume":"17","author":"Gilbert","year":"1995","journal-title":"Neurotoxicol. Teratol."},{"issue":"2","key":"10.1016\/j.toxlet.2016.01.008_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00365519409086523","article-title":"Diurnal variations in total forearm and skin microcirculatory blood flow in man","volume":"54","author":"Houben","year":"1994","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"21","key":"10.1016\/j.toxlet.2016.01.008_bib0050","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1021\/es502513w","article-title":"SHEDS-HT: an integrated probabilistic exposure model for prioritizing exposures to chemicals with near-field and dietary sources","volume":"48","author":"Isaacs","year":"2014","journal-title":"Environ. Sci. Technol."},{"issue":"12","key":"10.1016\/j.toxlet.2016.01.008_bib0055","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1002\/jps.24189","article-title":"A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies","volume":"103","author":"Lehman","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.toxlet.2016.01.008_bib0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1470-2045(15)00081-9","article-title":"Carcinogenicity of lindane DDT and 2 4-dichlorophenoxyacetic acid","volume":"16","author":"Loomis","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.toxlet.2016.01.008_bib0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2011.02.023","article-title":"Mathematical models of skin permeability: an overview","volume":"418","author":"Mitragotri","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.toxlet.2016.01.008_bib0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1015810312465","article-title":"Predicting skin permeability","volume":"9","author":"Potts","year":"1992","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.toxlet.2016.01.008_bib0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/026119291204000109","article-title":"The in vitro use of the hair follicle closure technique to study the follicular and percutaneous permeation of topically applied drugs","volume":"40","author":"Stahl","year":"2012","journal-title":"Altern Lab. Anim."},{"issue":"1","key":"10.1016\/j.toxlet.2016.01.008_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(89)90086-0","article-title":"GABAergic modulation of lindane (\u03b3-hexachlorocyclohexane)-induced seizures","volume":"100","author":"Su\u00f1ol","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.toxlet.2016.01.008_bib0085","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF00302386","article-title":"Relationship between lindane concentration in blood and brain and convulsant response in rats after oral or intraperitoneal administration","volume":"60","author":"Tusell","year":"1987","journal-title":"Arch. Toxicol."},{"issue":"239","key":"10.1016\/j.toxlet.2016.01.008_bib0090","first-page":"74905","article-title":"Lindane; cancellation order","volume":"71","author":"U.S.EPA","year":"2006","journal-title":"Fed. Regist."},{"key":"10.1016\/j.toxlet.2016.01.008_bib0095","series-title":"FDA public health advisory: Safety of topical lindane products for the treatment of scabies and lice","author":"US Food and Drug Administration","year":"2009"},{"issue":"15","key":"10.1016\/j.toxlet.2016.01.008_bib0100","first-page":"8479","article-title":"High-throughput models for exposure-based chemical prioritization in the expocast project","volume":"47","author":"Wambaugh","year":"2013","journal-title":"Environ. Sci. Technol."},{"issue":"6","key":"10.1016\/j.toxlet.2016.01.008_bib0105","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jps.20059","article-title":"Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds","volume":"93","author":"Yamazaki","year":"2004","journal-title":"J. Pharm. Sci."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741630008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741630008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:14:07Z","timestamp":1759900447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037842741630008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":21,"alternative-id":["S037842741630008X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.01.008","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}